Active, not recruiting
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
NCT03971461
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
- Locations
-
- NYU Langone Health New York, United States
- Cleveland Clinic Cleveland, Ohio, United States